Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to email@example.com so that we can defer those challenges. Your health and safety are paramount to us.
Posted 17 May 2013 | By Ansis Helmanis,
The European Commission's three Scientific Committees have been requested to provide a joint scientific opinion on the relationship of Synthetic Biology (SB) to genetic modification of organisms, its implications for human and animal health and the environment, and the major gaps in knowledge necessary for performing a reliable risk assessment.
Synthetic Biology is the term used to describe the creation of biological systems that do not exist in nature using engineering principles to better understand life processes, to generate and assemble functional modular components, and to develop novel applications or processes, such as products that produce, absorb or detect chemical substances of interest.
In December 2008, an expert working group was established by EU Member States to analyze a number of technologies, including synthetic genomics, to determine whether their use would produce a genetically modified organism as defined by the EU's directives on the deliberate release of genetically modified organisms (Directive 2001/18/EC) and on contained use of genetically modified micro-organisms (Directive 2009/41/EC).
The Working Group's report, finalized in December 2011, concluded that synthetic genomics (and more generally synthetic biology) is evolving so quickly and with such potential for new developments as compared to gene modification that the subject was too broad to discuss in the limited context of the Working Group.
The three EU Scientific Committees now asked to develop a joint scientific opinion are the Committee on Emerging and Newly Identified Health Risks (SCENIHR), the Committee on Consumer Safety (SCCS) and the Committee on Health and Environmental Risks (SCHER).
Scientific Committee Charge
RegLink Breaking News
Tags: Scientific Opinion, SCENIHR, Biotechnology, Synthetic Biology, EU